Search Results

Showing results 1 - 10 of 837.
Sort By: Date ▼

A new peanut allergy drug could cost $4,200 a year. Is it just overpriced peanut flour?

September 18, 2019


An FDA advisory panel this month recommended approval of an experimental treatment for peanut allergies but, writing in The Atlantic, James Hamblin questions whether the product is worth its likely $4,200 price tag—and flags research suggesting it might backfire for some patients.

Does pizza prevent cancer? The results of this year's Ig Nobel awards.

September 16, 2019


The Annals of Improbable Research on Thursday awarded the Ig Nobel Prizes to 10 "improbable" research projects, including studies into how dirty money really is, whether clickers can help train budding surgeons, and more.

Could a blood test help identify PTSD? Maybe, new study finds.

September 16, 2019


A new blood test has been shown to diagnose post-traumatic stress disorder (PTSD) in combat troops with a high level of accuracy, according to a study published last week in Molecular Psychiatry, which might help identify PTSD in troops who try to hide their symptoms.

CRISPR shown to be safe to target HIV (but unsuccessful so far)

September 13, 2019


A patient with HIV/AIDS who received transplanted stem cells edited with CRISPR to have a mutation that blocks HIV is living without side effects, providing evidence that the gene-editing technology can safely target HIV, according to a case study published Wednesday in the New England Journal of Medicine.

In the states: Florida provider pays $85K to settle alleged HIPAA violation, New York to require warnings in vape stores, and more

September 13, 2019


American Health Line rounds up the latest health care news in the states.

Your gut bacteria might be tied to obesity. (But fixing the problem won't be easy.)

September 12, 2019


Researchers are increasingly interested in the connection between the gut microbiome and obesity, but a new study from researchers at Massachusetts General Hospital suggests that transferring microbiota from a lean donor to an obese recipient might not improve the recipients' metabolic health, contrary to other research.

FTC cracks down on CBD products with unsupported claims they treat diseases

September 12, 2019


The Federal Trade Commission on Tuesday announced that it has warned three companies for advertising that their cannabidiol products can treat medical conditions without evidence to support those claims.

Men are missing out on 'lifesaving' breast cancer therapies—and FDA wants that to change

September 12, 2019


FDA recently released draft guidance that calls on researchers to include more male patients in clinical trials for breast cancer therapies in response to concerns that men are missing out on lifesaving treatments.

Google to ban ads for unproven cell, gene, and stem cell therapies

September 10, 2019


Google on Friday announced a new policy banning advertisements for "unproven or experimental medical techniques," including most cellular, gene, and stem cell therapies.

One family's $6M drug claim (and what it means for the future of rare diseases)

August 28, 2019


Dawn Patterson and two of her children have a rare bone disease, and the only treatment is a drug that was slated to cost $6 million a year—a high price tag that observers say is indicative of the pharmaceutical industry's growing interest in treatment for rare diseases.

Results Page: [Previous] 1 2 3 4 5  ... [Next]